Answer
Robaxin-750 product information reports that methocarbamol clearance was reduced by about 40% in patients with renal impairment receiving maintenance haemodialysis compared with a normal population, although mean elimination half-lives were similar (1.2 versus 1.1 hours, respectively).
Sources for this answer
- Robaxin-750Almirall Limited · emc · SmPC §5.2 Pharmacokinetic properties · Version 4Document updated
Sources checked